Literature DB >> 12167185

Age and sex as determinants of ventricular arrhythmic events in patients with decompensated congestive heart failure.

Andrew J Burger1, Doron Aronson.   

Abstract

BACKGROUND: The propensity to develop specific arrhythmias varies between the sexes and is influenced by age. Patients with congestive heart failure (CHF) have a high prevalence of ventricular ectopy. However, in the setting of CHF, it is not known whether sex-related or age-dependent differences exist in the susceptibility to arrhythmias.
METHODS: The study population included 134 men and 73 women (mean age 61 +/- 14 years) admitted for decompensated CHF. The severity of ventricular arrhythmias was assessed by 24-hour Holter monitoring. None of the patients were on parenteral vasoactive therapy during Holter recording.
RESULTS: All measures of ventricular ectopy were markedly lower in women. The average hourly premature ventricular contractions (PVCs), the frequency of ventricular pairs, the mean hourly repetitive ventricular beats, and the frequency of ventricular tachycardia episodes per 24 hours were 40%, 62%, 65%, and 78% lower in women, respectively. Multivariate logistic regression revealed that the risk of developing > 3 ventricular pairs per 24-hour period (OR = 2.2, CI = 1.1-4.2, P = 0.03), > 3 repetitive ventricular beats/hour (OR = 2.5, CI = 1.2-5.3, P = 0.01), or an episode of ventricular tachycardia (OR = 2.1, CI = 1.2-3.9, P = 0.01) were significantly higher in men. Patients in the higher tertile age group had a higher risk for the presence of > 3 ventricular pairs per 24-hour period (OR = 2.3, CI = 1.1-4.2, P = 0.03), and the presence of > 3 repetitive ventricular beats per hour (OR = 5.9, CI = 2.7-13.3, P < 0.0001), compared with patients in the lower age tertile.
CONCLUSION: Male sex and age are associated with complex ventricular ectopy in patients with CHF. Further understanding of the mechanisms involved in the relative protection conferred by female sex would advance our understanding about arrhythmias in heart failure.

Entities:  

Mesh:

Year:  2002        PMID: 12167185      PMCID: PMC7027671          DOI: 10.1111/j.1542-474x.2002.tb00169.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  40 in total

Review 1.  Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms, and evidence-based management, Part I.

Authors:  M O Sweeney
Journal:  Pacing Clin Electrophysiol       Date:  2001-05       Impact factor: 1.976

Review 2.  Sudden cardiac death.

Authors:  D P Zipes; H J Wellens
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

3.  Sex differences in sympathetic-adrenal medullary reactions induced by different stressors.

Authors:  M Frankenhaeuser; E Dunne; U Lundberg
Journal:  Psychopharmacology (Berl)       Date:  1976-05-05       Impact factor: 4.530

4.  Relation between gender, etiology and survival in patients with symptomatic heart failure.

Authors:  K F Adams; S H Dunlap; C A Sueta; S W Clarke; J H Patterson; M B Blauwet; L R Jensen; L Tomasko; G Koch
Journal:  J Am Coll Cardiol       Date:  1996-12       Impact factor: 24.094

5.  Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes.

Authors:  T Nakajima; K Iwasawa; H Oonuma; T Morita; A Goto; Y Wang; H Hazama
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Gender differences in survival in advanced heart failure. Insights from the FIRST study.

Authors:  K F Adams; C A Sueta; M Gheorghiade; C M O'Connor; T A Schwartz; G G Koch; B Uretsky; K Swedberg; W McKenna; J Soler-Soler; R M Califf
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

7.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

8.  Effect of age on postmyocardial infarction ventricular arrhythmias (Holter Registry data from CAST I and CAST II). Cardiovascular Arrhythmia Suppression Trials.

Authors:  R A Josephson; L A Papa; M M Brooks; M Morris; T Akiyama; H L Greene
Journal:  Am J Cardiol       Date:  1995-10-01       Impact factor: 2.778

9.  A new method for evaluating antiarrhythmic drug efficacy.

Authors:  M Sami; H Kraemer; D C Harrison; N Houston; C Shimasaki; R F DeBusk
Journal:  Circulation       Date:  1980-12       Impact factor: 29.690

10.  Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen.

Authors:  N A McHugh; S M Cook; J L Schairer; M M Bidgoli; G F Merrill
Journal:  Am J Physiol       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.